Evidence map›Paper›PMID 32185403›Full record

ReviewCellular and molecular life sciences : CMLS2020

Building sophisticated sensors of extracellular cues that enable mammalian cells to work as "doctors" in the body.

Ryosuke Kojima, Dominque Aubel, Martin Fussenegger

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Designer cell therapy for tissue regeneration.Inflammation and regeneration · 2024
    Review
  3. Engineering synthetic phosphorylation signaling networks in human cells.bioRxiv : the preprint server for biology · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. The evolution of synthetic receptor systems.Nature chemical biology · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Elucidation and refinement of synthetic receptor mechanisms.Synthetic biology (Oxford, England) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryosuke KojimaGraduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. kojima@m.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-3792-9222
Dominque AubelIUTA Département Génie Biologique, Université Claude Bernard Lyon 1, Boulevard du 11 Novembre 1918, 69622, Villeurbanne Cedex, France.
Martin FusseneggerDepartment of Biosystems Science and Engineering (D-BSSE), ETH Zurich, Mattenstrasse 26, 4058, Basel, Switzerland. martin.fussenegger@bsse.ethz.ch.ORCID http://orcid.org/0000-0001-8545-667X

Funding

European Research Council 785800
6 · The paper itself

Abstract

Mammalian cells are inherently capable of sensing extracellular environmental signals and activating complex biological functions on demand. Advances in synthetic biology have made it possible to install additional capabilities, which can allow cells to sense the presence of custom biological molecules and provide defined outputs on demand. When implanted/infused in patients, such engineered cells can work as intrabody "doctors" that diagnose disease states and produce and deliver therapeutic molecules when and where necessary. The key to construction of such theranostic cells is the development of a range of sensor systems for detecting various extracellular environmental cues that can be rewired to custom outputs. In this review, we introduce the state-of-art engineering principles utilized in the design of sensor systems to detect soluble factors and also to detect specific cell contact, and we discuss their potential role in treating intractable diseases by delivering appropriate therapeutic functions on demand. We also discuss the challenges facing these emerging technologies.

Indexed as

AnimalsBiosensing TechniquesExtracellular MatrixHumansLymphocytesReceptors, Chimeric AntigenReceptors, G-Protein-CoupledSynthetic BiologyTheranostic NanomedicineReceptors, Chimeric AntigenReceptors, G-Protein-CoupledBioengineeringCell-based sensorEngineered receptorsSynthetic biologyTheranostic cellsTransgene expression

Identifiers

PMID32185403
PMCPMC7452942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.